Clinical Trial Update: Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Hope Biosciences LLC is evaluating autologous adipose-derived mesenchymal stem cells for chronic traumatic brain injury an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cells (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences LLC | Conditions: Traumatic Brain Injury | Phase 2 | Status: RECRUITING